Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · IEX Real-Time Price · USD
25.08
-1.01 (-3.87%)
At close: Jul 19, 2024, 4:00 PM
25.00
-0.08 (-0.32%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
Intellia Therapeutics Market Cap
Intellia Therapeutics has a market cap or net worth of $2.42 billion as of July 22, 2024. Its market cap has decreased by -29.83% in one year.
Market Cap
2.42B
Enterprise Value
1.74B
1-Year Change
-29.83%
Ranking
Category
Stock Price
$25.08
Market Cap Chart
Since May 6, 2016, Intellia Therapeutics's market cap has increased from $757.50M to $2.42B, an increase of 219.42%. That is a compound annual growth rate of 15.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 2.42B | -11.39% |
| Dec 29, 2023 | 2.73B | -0.54% |
| Dec 30, 2022 | 2.75B | -68.80% |
| Dec 31, 2021 | 8.80B | 173.78% |
| Dec 31, 2020 | 3.21B | 348.19% |
| Dec 31, 2019 | 717.10M | 20.99% |
| Dec 31, 2018 | 592.70M | -14.55% |
| Dec 29, 2017 | 693.60M | 46.98% |
| Dec 30, 2016 | 471.90M | -37.70% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PTC Therapeutics | 2.50B |
| Ardent Health Partners | 2.48B |
| Integra LifeSciences Holdings | 2.47B |
| Vericel | 2.44B |
| Celldex Therapeutics | 2.42B |
| UFP Technologies | 2.40B |
| Myriad Genetics | 2.35B |
| CG Oncology | 2.35B |